Medical Condition News

RSS

New blood test to determine patients at low risk for rejection of transplanted hearts

After his heart transplant in 2005, Ramon Llenado underwent a biopsy every week, then every month, then every three months. Most heart transplant patients face a lifetime of these invasive tests, which involve snipping out tiny pieces of heart to check for possible organ rejection.

23 Apr 2010

Research associates diabetes with atrial fibrillation

As the U.S. population keeps aging and gaining weight, diabetes is becoming increasingly common. Some research has associated diabetes with the most common kind of chronically irregular heartbeat, called atrial fibrillation, which can raise the risk for stroke and death. But results of past studies of diabetes and atrial fibrillation have conflicted.

23 Apr 2010

Techniques to protect organs during bypass surgery impair autoregulation, increase risk of stroke: Study

The standard practice of cooling and then rewarming a patient to prevent organ damage during cardiac bypass surgery may impair the body's mechanism that controls blood flow to the brain, potentially increasing the patient's risk of stroke, new research from Johns Hopkins suggests.

23 Apr 2010

Interesting heart rate dynamics in premature infants

A normal healthy heart beats at a variable rate with extraordinarily complex fluctuations across a wide range of time scales. Reduced complexity of heart rate has both clinical and dynamical significance - it may provide warning of impending illness, or clues about the dynamics of the heart's pacemaking system.

23 Apr 2010

Nicotine poisoning linked to weight gain

A new study links nicotine poisoning with weight gain, and concludes tha active smokers, not only those who stop, put on more weight than non-smokers. After four years of analysis in the University of Navarra, those who put on least weight were those who had never smoked.

23 Apr 2010

New ways for earlier diagnosis of osteoarthritis

Researchers at King's College London's Department of Twin Research and Genetic Epidemiology, based at St Thomas' Hospital have discovered new ways of measuring biological markers in the blood which could be used to diagnose osteoarthritis earlier.

23 Apr 2010

New multi-faceted treatment program for young adults addicted to opioid drugs

A multi-faceted treatment program for young adults addicted to opioid drugs was unveiled today at the National Institute on Drug Abuse's Blending Conference in Albuquerque, N.M. This eighth meeting in the series brings together researchers and clinicians so their latest findings can be immediately applied to the needs of patients and their families dealing with addictive disorders.

23 Apr 2010

PCFT helps in effectively targeting cytotoxic antifolates to tumors: Study

Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit today presented a poster at the American Association for Cancer Research's 101st Annual Meeting 2010 that details their novel study of molecules that use a tumor's acidic microenvironment to help them tailor chemotherapeutic agents to kill the tumor.

23 Apr 2010

Alzheimer's Association's hosts conference to educate and support NH people with the disease

Alzheimer's disease can be devastating to families who become caregivers. Anyone seeking more information about Alzheimer's is invited to attend the Alzheimer's Association's "Care to Cure: the latest in research and care giving" conference on Saturday, May 22 in Concord.

23 Apr 2010

Hospitals striving to provide balloon angioplasties in under 60 minutes for patients undergoing heart attacks

National guidelines say patients undergoing heart attacks should receive balloon angioplasties as soon as possible or within 90 minutes of arriving at the hospital -- known as the "door-to-balloon time."

23 Apr 2010

Scientists develop new way of modifying viruses to seek out and destroy cancer cells

CANCER RESEARCH UK scientists at the University of Leeds have developed a new way of modifying viruses to seek out and destroy cancer cells, according to research published in Gene Therapy today1 (Friday).

23 Apr 2010

Potential new early cancer detection method using engineered gold nanoparticles

University of Missouri School of Medicine scientists explain a potentially new early cancer detection and treatment method using nanoparticles created at MU in an article published in the Proceedings of the National Academy of Sciences. The article illustrates how engineered gold nanoparticles tied to a cancer-specific receptor could be targeted to tumor cells to treat prostate, breast or lung cancers in humans.

23 Apr 2010

Study describes relationship between gene expression and intelligence in WS patients

Although genetics is the most significant known determinant of human intelligence, how specific genes affect intelligence remains largely unknown. A multi-institution team led by a University of Utah USTAR researcher has found that the brain gene STX1A plays a significant role in the level of intelligence displayed by patients with Williams Syndrome.

23 Apr 2010

CAPS launches new service for admixture and delivery of Hibernation Therapeutics' Adenocaine microplegia

Central Admixture Pharmacy Services, Inc. (CAPS®), a B. Braun company, announced today the launch of its newest service for the admixture and delivery of Hibernation Therapeutics' patented Adenocaine™ microplegia, the world's first low-potassium, non-depolarizing cardioplegia solution.

From B. Braun Melsungen AG 23 Apr 2010

Treating OSA in truck drivers lowers healthcare costs and disability rates: Study

For commercial motor vehicle drivers with obstructive sleep apnea, effective treatment lowers healthcare costs and disability rates, reports a study in the May Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.

23 Apr 2010

Hospital for Special Care launches ALS Clinical Trials Unit at Neuromuscular Center

Hospital for Special Care announced today the launch of the region's first Amyotrophic Lateral Sclerosis (ALS) Clinical Trials Unit at its Neuromuscular Center. The new unit will be headed by Jinsy A. Andrews, M.D., a physician researcher recruited from Columbia University. Dr. Andrews, Director of Research & Clinical Trials Unit, Hospital for Special Care, specializes in neuromuscular research and will facilitate the hospital's first clinical trial for ALS upon her arrival.

23 Apr 2010

Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive stomach cancer

Genentech, Inc., a wholly owned member of the Roche Group, announced today that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Herceptin® (trastuzumab) plus chemotherapy in people with advanced, HER2-positive adenocarcinoma of the stomach, including gastroesophageal junction cancer.

23 Apr 2010

Mayo Clinic study finds changes in tissue damage throughout the course of MS

A new Mayo Clinic study has found that the type of tissue damage changes throughout the course of multiple sclerosis. In early relapsing disease stages, the plaques, or areas where the nervous system is inflamed or demyelinated, are predominantly active with distinct heterogeneous patterns of myelin damage.

23 Apr 2010

COSMOS project launched to investigate link between use of mobile phones and health problems

A new decades-long study launches today to investigate whether there is a link between the use of mobile phones and long-term health problems such as cancer.

23 Apr 2010

Affymax institutes quiet period in connection with Hematide Phase 3 result analysis

Affymax, Inc. today announced that it has instituted a quiet period to curtail discussions with the investor community and the media in connection with the analysis of Phase 3 results for the investigational drug, Hematide, in four clinical trials (PEARL 1, PEARL 2, EMERALD 1 and EMERALD 2) which evaluated Hematide for the treatment of anemia in chronic renal failure patients.

23 Apr 2010

Medical Condition News

New blood test to determine patients at low risk for rejection of transplanted hearts

Research associates diabetes with atrial fibrillation

Techniques to protect organs during bypass surgery impair autoregulation, increase risk of stroke: Study

Interesting heart rate dynamics in premature infants

Nicotine poisoning linked to weight gain

New ways for earlier diagnosis of osteoarthritis

New multi-faceted treatment program for young adults addicted to opioid drugs

PCFT helps in effectively targeting cytotoxic antifolates to tumors: Study

Alzheimer's Association's hosts conference to educate and support NH people with the disease

Hospitals striving to provide balloon angioplasties in under 60 minutes for patients undergoing heart attacks

Scientists develop new way of modifying viruses to seek out and destroy cancer cells

Potential new early cancer detection method using engineered gold nanoparticles

Study describes relationship between gene expression and intelligence in WS patients

CAPS launches new service for admixture and delivery of Hibernation Therapeutics' Adenocaine microplegia

Treating OSA in truck drivers lowers healthcare costs and disability rates: Study

Hospital for Special Care launches ALS Clinical Trials Unit at Neuromuscular Center

Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive stomach cancer

Mayo Clinic study finds changes in tissue damage throughout the course of MS

COSMOS project launched to investigate link between use of mobile phones and health problems

Affymax institutes quiet period in connection with Hematide Phase 3 result analysis

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Latest News